検索
Milestone Pharmaceuticals Inc
MISTウォッチリストに追加
0.787USD
-0.075-8.70%
取引時間 09/24, 15:07（ET）
97.98M時価総額
損失額直近12ヶ月PER
Milestone Pharmaceuticals Incについて 企業名
Milestone Pharmaceuticals Inc. is a Canada-based biopharmaceutical company. The Company is focused on the development and commercialization of cardiovascular medicines. Its lead product candidate, etripamil, is a potent rapid-onset calcium channel blocker that the Company designed and is developing as a rapid-onset nasal spray to be administered by patients. The Company is also focused on developing etripamil to treat paroxysmal supraventricular tachycardia, atrial fibrillation, and other cardiovascular indications.
Milestone Pharmaceuticals Inc プロフィール
企業コードMIST
会社名Milestone Pharmaceuticals Inc
上場日May 09, 2019
最高経営責任者「CEO」Oliveto (Joseph)
従業員数33
証券種類Ordinary Share
決算期末May 09
本社所在地420-1111 boul. Dr.-Frederik-Philips
都市MONTREAL
証券取引所NASDAQ OMX - NASDAQ BASIC
国Canada
郵便番号H4M 2X6
電話番号15143360444
ウェブサイトhttps://www.milestonepharma.com
企業コードMIST
上場日May 09, 2019
最高経営責任者「CEO」Oliveto (Joseph)
Milestone Pharmaceuticals Incの経営陣
会社名
会社名/ポジション
ポジション
株式保有
変動額
Dr. David Bharucha
Dr. David Bharucha
Chief Medical Officer
Chief Medical Officer
113.18K
-13.36%
Dr. David Bharucha
Dr. David Bharucha
Chief Medical Officer
Chief Medical Officer
113.18K
-13.36%
Dr. David Bharucha
Dr. David Bharucha
Chief Medical Officer
Chief Medical Officer
113.18K
-13.36%
Mr. Joseph C. Papa
Mr. Joseph C. Papa
Independent Director
Independent Director
100.00K
--
Mr. Joseph C. Papa
Mr. Joseph C. Papa
Independent Director
Independent Director
100.00K
--
Mr. Joseph C. Papa
Mr. Joseph C. Papa
Independent Director
Independent Director
100.00K
--
Mr. Amit Hasija
Mr. Amit Hasija
Chief Financial Officer, Executive Vice President - Corporate Development
Chief Financial Officer, Executive Vice President - Corporate Development
99.85K
-19.23%
Mr. Amit Hasija
Mr. Amit Hasija
Chief Financial Officer, Executive Vice President - Corporate Development
Chief Financial Officer, Executive Vice President - Corporate Development
99.85K
-19.23%
Mr. Amit Hasija
Mr. Amit Hasija
Chief Financial Officer, Executive Vice President - Corporate Development
Chief Financial Officer, Executive Vice President - Corporate Development
99.85K
-19.23%
Dr. Robert James Wills, Ph.D.
Dr. Robert James Wills, Ph.D.
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
65.00K
--
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Dr. David Bharucha
Dr. David Bharucha
Chief Medical Officer
Chief Medical Officer
113.18K
-13.36%
Dr. David Bharucha
Dr. David Bharucha
Chief Medical Officer
Chief Medical Officer
113.18K
-13.36%
Dr. David Bharucha
Dr. David Bharucha
Chief Medical Officer
Chief Medical Officer
113.18K
-13.36%
Mr. Joseph C. Papa
Mr. Joseph C. Papa
Independent Director
Independent Director
100.00K
--
Mr. Joseph C. Papa
Mr. Joseph C. Papa
Independent Director
Independent Director
100.00K
--
Mr. Joseph C. Papa
Mr. Joseph C. Papa
Independent Director
Independent Director
100.00K
--
よくある質問
Milestone Pharmaceuticals Incの上位5名の株主は誰ですか？
Milestone Pharmaceuticals Incの上位5名の株主は以下のとおりです。Dr. David Bharucha
Milestone Pharmaceuticals Inc（MIST）の株式を保有している機関の数はいくつですか？
2026Q1時点で、Milestone Pharmaceuticals Incの株式を保有している機関は133社あり、保有株式の総市場価値は約30.89Mで、全体の25.86%を占めています。2025Q4と比較して、機関の持ち株は-18702702.00増加しています。